New observations on procoagulant properties of amniotic fluid: Microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma

Thrombosis Research

Volumn 132, Issue 6, 2013, Pages 757-760

  Uszyński, Waldemar ^a   Zekanowska, Ewa ^b   Uszyński, Mieczysław ^b   Zyliński, Andrzej ^c   Kuczyński, Jarosław ^d  

^a Regional Hospital in Włocławek   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c Regional Hospital in Suwa ki   (Poland)

^d State Vocational College in Suwa ki   (Poland)

Author keywords

Amniotic fluid; Microparticles; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

PROTEIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MATERNAL BLOOD; MEMBRANE MICROPARTICLE; PLASMA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AF; AMNIOTIC FLUID; MICROPARTICLES; MPS; MPS-TF; PHOSPHATIDYLSERINE; PS; TF; TFPI; TISSUE FACTOR; TISSUE FACTOR BEARING MPS; TISSUE FACTOR PATHWAY INHIBITOR;

AMNIOTIC FLUID; CELL-DERIVED MICROPARTICLES; FEMALE; FETAL BLOOD; HUMANS; PREGNANCY; THROMBOPLASTIN;

EID: 84889879357     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.10.001     Document Type: Article

References (25)

1. A. Piccin, W.G. Murphy, and O.P. Smith Circulating microparticles: pathophysiology and clinical implications Blood Rev 21 2007 157 171
2. B. Toth, A.R. Lok, A. Boing, M. Diamant, J.A.M. van der Post, and K. Friese Microparticles and exosomes: Impact on normal and complicated pregnancy Am J Reprod Immunol 58 2007 389 402
3. C.W.G. Redman, and I.L. Sargent Circulating microparticles in normal pregnancy and pre-eclampsia Placenta 22 2008 73 77 [Suppl.]
4. F. Bretelle, F. Sabatier, D. Desprez, L. Camoin, L. Grunebaum, and U. Combes Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction Thromb Haemost 89 2003 486 492
5. V.H. Gonzales-Quintero, J.J. Jimenez, W. Jy, L.M. Mauro, L. Hortman, and M.J. O'Sullivan Elevated plasma endothelial microparticles in preeclampsia Am J Obstet Gynecol 189 2003 589 593
6. ChAR Lok, R. Nieuwland, A. Struk, ChiM Hau, K. Boer, and E. Vanbavel Microparticle-associated P-selectin reflects platelet activation in preeclampsia Platelets 18 2007 68 72
7. M. Grundmann, A. Woywodt, T. Kirscht, B. Holwitz, K. Ochler, and U. Erdbruegger Circulating endothelial cells: a marker of vascular damage in patients with preeclampsia Am J Obstet Gynecol 198 2008 317.e1 317.e5
8. ChAR Lok, J.A.M. Van Der Post, I.L. Sargent, ChiM Hau, A. Sturk, and K. Boer Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia Hypertens Pregnancy 27 2008 344 360
9. ChAR Lok, J. Jebbink, R. Nieuwland, M.M. Faas, K. Boer, and A. Struk Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia Am J Reprod Immunol 61 2009 346 359
10. S. Nomura, Y. Ozaki, and Y. Ikeda Function and role of microparticles in various clinical settings Thromb Res 123 2008 8 23
11. A. Aharon, S. Katzenell, T. Tamari, and B. Brenner Microparticles bearing tissue factor and tissue pathway inhibitor in gestational vascular complications J Thromb Haemost 7 2009 1047 1050
12. N.S. Key Analysis of tissue factor positive microparticles Thromb Res 125 2010 42 45 [Suppl.]
13. J.-M. Freyssinet, and F. Toti Formation of procoagulant microparticles and properties Thromb Res 125 2010 46 48 [Suppl.]
14. E.R. Vandendries, B.C. Furie, and B. Furie Role of P-selectin and PSGL-1 in coagulation and thrombosis Thromb Haemost 92 2004 459 466
15. N. Satta, F. Toti, E. Fressinaud, D. Meyer, and J.M. Freyssinet Scott syndrome: an inherited defect of the procoagulant activity of platelets Platelets 8 1997 17 24
16. M. Uszyński, E. Zekanowska, W. Uszyński, and J. Kuczyński Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism Eur J Obstet Gynecol Reprod Biol 95 2003 163 166
17. G. Sarig, AdiJ Klil-Drori, Chap-Marshak, B. Brenner, and A. Drugan Activation of coagulation in amniotic fluid during normal pregnancy Thromb Res 128 2011 490 495
18. M.N.A. Hussein, A.N. Boing, E. Biro, F.J. Hoek, G.M.T. Vogel, and D.G. Meuleman Phospholipid composition of in vitro endothelial micoparticles and their in vivo thrombogenic properties Thromb Res 121 2008 865 871
19. Th. Luther, N. Mackman, C. Bierhaus, M. Kasper, and S. Albrecht Tissue factor expression during human and mouse development Am J Pathol 149 1996 101 113
20. O. Tyden, S. Bergstrom, and B.A. Nillson Origin of amniotic fluid cells in mid-trimester pregnancies Br J Obstet Gynecol 88 1980 278 286
21. J. Zhou, S. Liu, M. Ma, J. Hou, H. Yu, and Lu. Ch Procoagulant activity and phosphatidylserine of amniotic fluid cells Thromb Haemost 101 2009 845 851
22. R.A. Brace Physiology of amniotic fluid volume regulation K.A. Rao, M.G. Ross, Amniotic fluid 1999 Prism Books Pvt Ltd. Bangalore s.110 s.132
23. M. Uszyński Amniotic fluid embolism: Literature review and integrated concept of pathomechanism Open J Obstet Gynecol 1 2011 178 183
24. W. Uszyński, M. Uszyński, and E. Zekanowska Thrombin markers in pregnant women: Measurements of prothrombin fragments F 1 + 2 and trombin-antithrombin III complexes (TAT) in the cord blood, the mother's blood and in amniotic fluid (in Polish) Gin Pol 75 2004 595 602
25. M. Uszyński, E. Zekanowska, W. Uszyński, J. Kuczyński, and A. Zyliński Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs Eur J Obstet Gynecol Reprod Biol 158 2011 37 41